Is Novavax A Buy Right Now? A Look At The Stock And Its Coronavirus Vaccine Candidate
Over the course of the past 12 months, Novavax has gone from penny stock status before the pandemic to skyrocketing more than 2,700% over the course of the pandemic thus far.
